ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

GMAB Genmab AS

29.73
2.01 (7.25%)
May 03 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Genmab AS GMAB NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
2.01 7.25% 29.73 18:05:20
Open Price Low Price High Price Close Price Previous Close
29.73 29.46 29.92 29.72 27.72
more quote information »

Recent News

Date Time Source Heading
4/29/202417:40BWFDA Grants Full Approval for TIVDAK® to Treat Recurrent or..
4/03/202400:35BWGenmab to Broaden and Strengthen Oncology Portfolio with..
3/11/202412:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/04/202412:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/04/202412:26EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
3/01/202416:04EDGAR2Form 144 - Report of proposed sale of securities
2/29/202410:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/28/202410:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/27/202415:55EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/27/202406:45BWU.S. FDA Accepts for Priority Review the Supplemental..
2/26/202411:19EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/26/202409:40EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/22/202415:28EDGAR2Form S-8 - Securities to be offered to employees in employee..
2/20/202410:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/14/202414:42EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/14/202412:49EDGAR2Form 20-F - Annual and transition report of foreign private..
2/14/202411:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/02/202405:45BWTisotumab Vedotin Marketing Authorization Application..
1/31/202410:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/23/202408:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/09/202406:45DJNPfizer, Genmab Get Speedy FDA Review of Tivdak Full Approval
1/09/202405:45BWTIVDAK® (tisotumab vedotin-tftv) Supplemental Biologics..
1/03/202407:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/13/202310:46EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/09/202311:00BWNew Pivotal Data for Bispecific Antibody Epcoritamab..
12/01/202312:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/27/202306:00BWGenmab Announces Positive Regulatory Updates for Epcoritamab..
11/21/202315:51EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/09/202309:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/08/202311:24EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/07/202310:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/02/202308:05BWGenmab Announces Multiple Abstracts to be Presented at the..
10/22/202309:30BWTIVDAK® (tisotumab vedotin-tftv) Significantly Prolonged..
10/17/202307:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/05/202309:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/28/202315:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/25/202307:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/25/202307:50DJNAbbVie, Genmab Get Conditional Europe OK of Tepkinly..
9/25/202306:45BWGenmab Announces European Commission Approval of TEPKINLY®..
9/25/202304:55BWEPKINLY™ (epcoritamab) Approved by Japan Ministry of Health,..
9/13/202308:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/12/202314:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/05/202308:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/04/202314:00BWSeagen and Genmab Announce TIVDAK® (tisotumab vedotin-tftv)..
8/16/202312:44EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/15/202314:06EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/03/202310:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/21/202308:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
7/21/202303:30BWGenmab Announces AbbVie Receives Positive CHMP Opinion for..
7/20/202308:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

Your Recent History

Delayed Upgrade Clock